Statistical analysis

YL Yujia Liu
XX Xianchao Xiao
CS Chenglin Sun
ST Suyan Tian
ZS Zhonghua Sun
YG Ying Gao
YL Yazhen Li
JC Jie Cheng
YL You Lv
ML Mei Li
ZL Zhuo Li
YZ Yumin Zhang
GW Gang Wang
YL Yang Liu
YG Yuan Gao
LZ Liwen Zhu
YL Yan Liu
GW Guixia Wang
request Request a Protocol
ask Ask a question
Favorite

Statistical analyses were carried out using spss (version 18.0; IBM Corporation, Armonk, NY, USA) and open‐source R (version 2.15.1; Auckland University, Auckland, New Zealand) software. Data were plotted with Graph Pad Prism software (version 5.0; GraphPad Software; La Jolla, CA, USA). Continuous variables are presented as the mean ± standard deviation; the t‐test was used for comparison between two groups, and the F‐test (analysis of variance) was used for comparison of groups of more than two. Categorical variables were expressed as percentages. The χ2‐test was used for comparison between multiple groups. A P‐value <0.05 was considered statistically significant.

The receiver operating characteristic (ROC) curves were achieved using open‐source R software (version 2.15.1; Auckland University) and the p‐ROC package23. In the present study, two ROC curves were plotted: one for people diagnosed with diabetes, and the other for people diagnosed with prediabetes by FPG, 2 h‐PPG and HbA1c, respectively. In general, an area under the curve (AUC) >0.9 indicates a high diagnostic value, 0.7 < AUC ≤ 0.9 indicates a moderate diagnostic value, and 0.5 < AUC ≤ 0.7 indicates a low diagnostic value. Optimal cut‐off values were obtained based on the highest Youden index across various cut‐off points as reviewed previously24.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A